Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy

References

• LadensteinRPotschgerULe DeleyMCPrimary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trialJ Clin Oncol201028203284329120547982
   PubMed Web of Science ®Google Scholar
• EsiashviliNGoodmanMMarcusRBJrChanges in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results dataJ Pediatr Hematol Oncol200830642543018525458
   PubMed Web of Science ®Google Scholar
• BeniniSZuntiniMManaraMCInsulin-like growth factor binding protein 3 as an anticancer molecule in Ewing’s sarcomaInt J Cancer200611951039104616570284
   PubMedGoogle Scholar
• PrieurATirodeFCohenPDelattreOEWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3Mol Cell Biol200424167275728315282325
   PubMed Web of Science ®Google Scholar
• JonesJIClemmonsDRInsulin-like growth factors and their binding proteins: biological actionsEndocr Rev19951613347758431
   PubMed Web of Science ®Google Scholar
• van MaldegemAMBoveeJVPeterseEFHogendoornPCGelderblomHEwing sarcoma: the clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathwayEur J Cancer20165317118026765686
   PubMed Web of Science ®Google Scholar
• RenehanAGZwahlenMMinderCO’dwyerSTShaletSMEggerMInsulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisLancet200436394181346135315110491
   PubMed Web of Science ®Google Scholar
• PollakMInsulin and insulin-like growth factor signalling in neoplasiaNat Rev Cancer200881291592819029956
   PubMed Web of Science ®Google Scholar
• JanknechtREWS-ETS oncoproteins: the linchpins of Ewing tumorsGene200536311416202544
   PubMedGoogle Scholar
• StewartCERotweinPGrowth, differentiation, and survival: multiple physiological functions for insulin-like growth factorsPhysiol Rev1996764100510268874492
   PubMed Web of Science ®Google Scholar
• HoALSchwartzGKTargeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: unfulfilled promise or a promising beginning?J Clin Oncol2011294581458322025158
   PubMed Web of Science ®Google Scholar
• ChavesJSaifMWIGF system in cancer: from bench to clinicAnticancer Drugs201122320621221178765
   PubMedGoogle Scholar
• IamsWTLovlyCMMolecular pathways: clinical applications and future direction of insulin-like growth factor-1 receptor pathway blockadeClin Cancer Res201521194270427726429980
   PubMed Web of Science ®Google Scholar
• Van der WoudeHJBloemJLTaminiauAHNooyMAHogendoornPCClassification of histopathologic changes following chemotherapy in Ewing’s sarcoma of boneSkeletal Radiol19942375015077824975
   PubMedGoogle Scholar
• Van der WoudeHJBloemJLHolscherHCMonitoring the effect of chemotherapy in Ewing’s sarcoma of bone with MR imagingSkeletal Radiol19942374935007824974
   PubMedGoogle Scholar
• AltmanDGMcShaneLMSauerbreiWTaubeSEReporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationPLoS Med20129e100121622675273
   PubMed Web of Science ®Google Scholar
• BidlingmaierMFriedrichNEmenyRTReference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendationsJ Clin Endocrinol Metab20149951712172124606072
   PubMed Web of Science ®Google Scholar
• FriedrichNWolthersODArafatAMAge- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assaysJ Clin Endocrinol Metab20149951675168624483154
   PubMed Web of Science ®Google Scholar
• RaffertyBRigsbyPGaines-DasREMulticentre collaborative study to calibrate IGF-II by bioassay and immunoassay: establishment of the First WHO Reference ReagentGrowth Horm IGF Res2001111182311437470
   PubMedGoogle Scholar
• ContalCO’QuigleyJAn application of changepoint methods in studying the effect of age on survival in breast cancerComput Stat Data Anal1999303253270
   Web of Science ®Google Scholar
• Tunes-da-SilvaGKleinJPCutpoint selection for discretizing a continuous covariate for generalized estimating equationsComput Stat Data Anal201155122623522639478
   PubMedGoogle Scholar
• SchemperMSmithTLA note on quantifying follow-up in studies of failure timeControl Clin Trials19961743433468889347
   PubMedGoogle Scholar
• The Comprehensive R Archive Network [homepage on the Internet] Available from cran.r-project.org/2015Accessed March 3, 2016
   Google Scholar
• CotterillSJAhrensSPaulussenMPrognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study GroupJ Clin Oncol200018173108311410963639
   PubMed Web of Science ®Google Scholar
• SchumacherBGarinisGAHoeijmakersJHAge to survive: DNA damage and agingTrends Genet2008242778518192065
   PubMedGoogle Scholar
• ScotlandiKManaraMCSerraMExpression of insulin-like growth factor system components in Ewing’s sarcoma and their association with survivalEur J Cancer20114781258126621345666
   PubMed Web of Science ®Google Scholar
• ToretskyJASteinbergSMThakarMInsulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumorsCancer200192112941294711753970
   PubMedGoogle Scholar
• ShaoYYHuangCCLinSDHsuCHChengALSerum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapyClin Cancer Res201218143992399722623732
   PubMedGoogle Scholar
• ElmashadNIbrahimWSMayahWWPredictive value of serum insulin-like growth factor-1 in hepatocellular carcinomaAsian Pac J Cancer Prev201516261361925684496
   PubMedGoogle Scholar
• KasebAOMorrisJSHassanMMClinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinomaJ Clin Oncol201129293892389921911725
   PubMed Web of Science ®Google Scholar
• TasFKarabulutSBilginETastekinDDuranyildizDClinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancerTumour Biol20143599303930924943688
   PubMedGoogle Scholar
• TasFKarabulutSSerilmezMCiftciRDuranyildizDClinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancerTumour Biol20143543125313224254307
   PubMedGoogle Scholar
• ChoEJLeeJHYooJJSerum insulin-like growth factor-I level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: a prospective cohort studyClin Cancer Res201319154218422723757355
   PubMedGoogle Scholar
• GallegoRCodony-ServatJGarcia-AlbenizXSerum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancerEndocr Relat Cancer200916131131719109398
   PubMedGoogle Scholar
• HuangYFChengWFWuYPChengYMHsuKFChouCYCirculating IGF system and treatment outcome in epithelial ovarian cancerEndocr Relat Cancer201421221722924273235
   PubMedGoogle Scholar
• WatanabeSTamuraTOnoKInsulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectinEur J Heart Fail201012111214122220851819
   PubMedGoogle Scholar
• JiaTGamaATHeimburgerOIGF-1 and survival in ESRDClin J Am Soc Nephrol20149112012724178975
   PubMed Web of Science ®Google Scholar
• BorinsteinSCBarkauskasDAKrailoMInvestigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children’s Oncology GroupCancer2011117214966497621480204
   PubMed Web of Science ®Google Scholar
• YeeDFavoniRELebovicGSInsulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factorJ Clin Invest1990866180618142174908
   PubMedGoogle Scholar
• YeeDPaikSLebovicGSAnalysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancerMol Endocrinol1989335095172747657
   PubMedGoogle Scholar
• ScotlandiKBeniniSSartiMInsulin-like growth factor I receptor-mediated circuit in Ewing’s sarcoma/peripheral neuroectodermal tumor: a possible therapeutic targetCancer Res19965620457045748840962
   PubMed Web of Science ®Google Scholar
• ScartozziMMandolesiAGiampieriRInsulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecanInt J Cancer201012781941194720099280
   PubMed Web of Science ®Google Scholar
• de GrootSCharehbiliAvan LaarhovenHWInsulin-like growth factor 1 receptor expression and IGF1R 3129G. T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Breast Cancer Res2016181326738606
   PubMedGoogle Scholar
• HeskampSBoermanOCMolkenboer-KuenenJDUpregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patientsPLoS One2015102e011774525680198
   PubMedGoogle Scholar
• AliOCohenPLeeKWEpidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer moleculeHorm Metab Res20033511–1272673314710351
   PubMedGoogle Scholar
• KümmelSEggemannHLuftnerDSignificant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodesInt J Biol Markers200722318619317922461
   PubMedGoogle Scholar
• LivingstoneCIGF2 and cancerEndocr Relat Cancer2013206R321R33924080445
   PubMed Web of Science ®Google Scholar
• SteigenSESchaefferDFWestRBNielsenTOExpression of insulin-like growth factor 2 in mesenchymal neoplasmsMod Pathol200922791492119407853
   PubMedGoogle Scholar